Web Analytics

3 Latest Announced Rounds

  • $5,000,000
    Seed

    1 Investors

    Biotechnology
    Sep 13th, 2024
  • $2,000,000
    Unknown

    1 Investors

    Manufacturing
    Sep 13th, 2024
  • $22,500,000
    Series A

    3 Investors

    Professional Training & Coaching
    Sep 13th, 2024
$1,681.62M Raised in 63 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Ancilia Biosciences

start up
United States - New York, New York
  • 29/08/2024
  • Unknown
  • $4,200,000

Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.


Related People

Alexandra SakatosCo Founder

Alexandra Sakatos United States - New York City Metropolitan Area

N/A